JAMA oncology
Journal
Overview
publication venue for
-
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group..
11.
2025
-
Uncertain Prognostic Impact of Visceral Pleural Invasion-Reply.
2025
-
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies..
11.
2025
-
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.
2024
-
Hairy Kidneys and Sclerotic Bone Lesions..
10.
2024
-
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer..
10.
2024
-
Heartbreaker.
2024
-
Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial..
10.
2024
-
Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer..
10.
2024
-
Hormone Deprivation-Free Survival-Inequities Persist in Research Priorities for Patients With Cancer.
2024
-
Second Primary Breast Cancer in Young Breast Cancer Survivors..
10.
2024
-
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
2023
-
Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer..
9.
2023
-
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US..
9.
2023
-
Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases..
9.
2023
-
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
2023
-
Immunotherapy in the Treatment of Localized Genitourinary Cancers.
2023
-
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer..
8.
2022
-
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.
2022
-
Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial..
8.
2022
-
Brain Metastasis-A Distinct Oncologic Disease Best Served by an Integrated Multidisciplinary Team Approach..
8.
2022
-
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group..
7.
2021
-
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19..
7.
2021
-
Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial..
7.
2021
-
Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase..
7.
2021
-
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial..
7.
2021
-
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic EGFR-Mutant Lung Cancers: A Phase 1/2 Single-Group Open-Label Trial..
6.
2020
-
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial..
6.
2020
-
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial..
6.
2020
-
Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care..
6.
2020
-
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study..
5.
2019
-
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial..
5.
2019
-
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab..
5.
2019
-
Pathogenic Germline Variants in Patients With Metastatic Breast Cancer..
5.
2019
-
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma..
5.
2019
-
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality..
5.
2019
-
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment..
5.
2019
-
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy..
5.
2019
-
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade..
5.
2019
-
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study..
5.
2019
-
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program..
5.
2019
-
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer..
5.
2019
-
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial..
4.
2018
-
Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening..
4.
2018
-
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial..
4.
2018
-
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women..
4.
2018
-
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer: Secondary Analysis of the NeoALTTO Randomized Clinical Trial..
4.
2018
-
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors..
4.
2018
-
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial..
4.
2018
-
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial..
4.
2018
-
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer..
4.
2018
-
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma..
4.
2018
-
Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer..
4.
2018
-
Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer..
4.
2018
-
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018..
4.
2018
-
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial..
4.
2018
-
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer..
4.
2018
-
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing..
4.
2018
-
Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials..
4.
2018
-
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial..
4.
2018
-
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma..
4.
2018
-
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome..
4.
2018
-
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study..
4.
2018
-
Financial Conflicts of Interest Among Oncology Clinical Pathway Vendors..
4.
2018
-
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer..
4.
2018
-
Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer..
4.
2018
-
Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma..
4.
2018
-
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials..
3.
2017
-
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques..
3.
2017
-
Sickness..
3.
2017
-
Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer..
3.
2017
-
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer..
3.
2017
-
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial..
3.
2017
-
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033..
3.
2017
-
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)..
3.
2017
-
Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial..
3.
2017
-
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States..
3.
2017
-
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform..
3.
2017
-
Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review
2017
-
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer..
2.
2016
-
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations..
2.
2016
-
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial..
2.
2016
-
An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials..
2.
2016
-
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial..
2.
2016
-
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors..
2.
2016
-
Racial/Ethnic Disparities in Genomic Sequencing..
2.
2016
-
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic..
2.
2016
-
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial..
2.
2016
-
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer..
2.
2016
-
Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study..
2.
2016
-
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva..
2.
2016
-
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer..
2.
2016
-
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer..
2.
2016
-
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage..
1.
2015
-
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)..
1.
2015
-
Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality..
1.
2015
-
Breast Cancer in Young Women: Rare Disease or Public Health Problem?.
1.
2015
-
Appropriate Use of Psychology in Patient-Physician Communication: Influencing Wisely..
1.
2015
-
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life..
1.
2015
-
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma..
1.
2015
-
Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the Horse..
1.
2015
-
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials..
1.
2015
-
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response..
1.
2015
-
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma..
1.
2015
-
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer..
1.
2015
-
The Cost and Value of Anti-Epidermal Growth Factor Receptor Therapies: Let's Not Be Rash..
1.
2015
-
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma..
1.
2015
-
Population-Based Assessment of Determining Treatments for Prostate Cancer..
1.
2015
-
Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma
-
Shaping the Path for a Global Oncology Academic Career..
5.
2019
-
Association of Breast Implants With Anaplastic Large-Cell Lymphoma..
4.
2018
-
Prognostic and Predictive Value of a Breast Cancer Expression Signature in Localized Prostate Cancer..
3.
2017
-
Laparoscopic Rectal Resection-Ready for Prime Time?.
3.
2017
-
Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails"..
2.
2016
-
Evaluating Chemotherapy at the End of Life--Reply..
2.
2016
-
Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain..
1.
2015
-
Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial..
1.
2015
-
Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps..
1.
2015
-
Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to Prostatectomy.
2021
-
A Race-Conscious Analysis of the Use of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding.
2021
-
Less Intense Dosing Schedule for a Bone-Modifying Agent.
2017
-
Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events.
2023
-
Inappropriate Use of the Same Cutoff by Different Sequencing Panels for Tumor Mutation Burden as Immunotherapy Biomarker-Reply.
2021
-
Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma.
2020
-
Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays.
2018
-
Assessment of Electronic Alert to Reduce Overuse of Granulocyte Colony-Stimulating Factor in Patients Hospitalized for Febrile Neutropenia.
2018
-
Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality.
2018
-
The Use of Superlatives in Cancer Research.
2016
-
Decision Making About Treatment for Advanced Cancer-Reply.
2015
-
Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer-Reply.
2015
-
Minimal Residual Disease in Patients With Nonmetastatic Triple-Negative Breast Cancer: Positive, Negative, or a More Complex Issue?.
6.
2020
-
PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions..
4.
2018
-
Perspectives on Cost and Value in Cancer Care..
2.
2016
-
Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.
2017
-
Prognostic and Predictive Insights From Genomic Assays for Breast Cancer in Diverse Populations: A Review.
2025
-
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.
2025
-
An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
2020
-
Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
2019
-
Delays in the Publication of Important Clinical Trial Findings in Oncology.
2018
-
Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis.
2018
-
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.
2016
-
Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review.
2016
-
Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
2016
-
Role of Local Radiation Therapy in Cancer Immunotherapy.
2015
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)